Department: Biostatistics

Frank Rockhold received a B.A. in Statistics from the University of Connecticut, an Sc.M. in Biostatistics from Johns Hopkins University and a Ph.D. in Biostatistics from VCU. He is currently senior vice president, global clinical safety and pharmacovigilance at GlaxoSmithKline Pharmaceuticals Research and Development and co-chair of the GSK Global Safety Board. His responsibilities include case management, signal detection, safety evaluation, risk management for all development and marketed products. In his 20 years at GSK, he has also held management positions within the Statistics and Epidemiology Department and Clinical Operations, both in R&D and in the U.S. Pharmaceutical Business, most recently serving as interim head of the Cardiovascular and Metabolic Medicines Development Center. Rockhold previously held positions of research statistician at Lilly Research Laboratories (1979-87) and executive director of biostatistics, data management and health economics at Merck Research Laboratories (1994-97). He has held several academic appointments at Butler University, Indiana University, Penn State University and the University of Pennsylvania.

Rockhold is currently chairman of the Board of Directors of the Clinical Data Interchange Standards Consortium and a member of the National Library of Medicine Advisory group for ClinicalTrials.Gov. He is past president for the Society for Clinical Trials, past chair for PhRMA Biostatistics Steering Committee and a member of the ICH E-9 and E-10 Expert Working Groups. He previously served as associate editor for Controlled Clinical Trials. He is a fellow of the American Statistical Association and a fellow of the Society for Clinical Trials. The author of more than 140 publications and abstracts, Rockhold is also a recipient of the PhRMA Career Achievement award.

 

Back to Listing